Hand osteoarthritis Musculoskeletal Diseases Other rheumatoid arthritis
Conditions
Interventions
Please note that, as of 08/04/2008, the anticipated start date of this trial was updated from 01/09/2007 to 15/04/2008.
Participants will be randomly allocated to the following two groups:
Group 1:
Sponsors
Diakonhjemmet Hospital (Norway)
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria updated as of 08/04/2008: 1. Age between 18 and 80 years 2. Hand osteoarthritis according to the American College of Rheumatology (ACR) criteria 3. Ability to communicate in Norwegian Inclusion criteria provided at time of registration: 1. Age between 18 and 75 years 2. Rheumatoid Arthritis (RA), Juvenile Ideopatic Arthritis (JIA) or Psoriatic Arthritis (PsA) according to the American College of Rheumatology (ACR) criteria 3. Ability to communicate in Norwegian
Exclusion criteria
Exclusion criteria: Exclusion criteria updated as of 08/04/2008: 1. Cognitive or mental impairment 2. Hand surgery within the last 6 months 3. Change in medication within the last month 4. Impaired hand function due to trauma or diseases other than hand osteoarthritis Exclusion criteria provided at time of registration: 1. Surgery within the last 6 months 2. Cognitive impairment or mental disease 3. Change in medication within the last month 4. Need for assistive technology due to surgery or to be able to be discharged from hospital
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome measures amended as of 22/04/2008: The following will be assessed at baseline and three months: 1. Activity and participation, measured with the Canadian Occupational Performance Measure (COPM) 2. Pain during performance of prioritised activities, measured on visual analogue scales Primary outcome measures provided at time of registration: The following will be measured at baseline, 6 and 12 months: 1. Activity and participation, measured with the Canadian Occupational Performance Measure (COPM) 2. Pain during performance of prioritised activities, measured on visual analogue scales | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measures amended as of 22/04/2008: The following will be assessed at baseline and three months: 1. Hand function, measured with the pain, stiffness and function subscales of the Australian/Canadian hand osteoarthritis measure (AUSCAN) 2. Functional ability, measured with the Modified health Assessment Questionnaire (MHAQ) 3. Hand pain, general pain, fatigue and disease activity, measured on visual analogue scales 4. Cost-effectiveness, measured with the Quality of Life Questionnaire (EQ-5D) and patient reported use of medication and health care resources Secondary outcome measures provided at time of registration: The following will be measured at baseline and 6 and 12 months: 1. Fatigue, measured with the Fatigue Impact Scale (FIS) 2. Quality of life, measured with the Arthritis Impact Scale (AIMS2) 3. Pain, fatigue and disease activity, measured on visual analogue scales. 4. Functional ability, measured with the Modified Health Assessment Questionnaire (MHAQ). 5. Cost-effectiveness, measured with the Quality of Life Questionnaire (15D) and patient reported use of medications and health care resources | — |
Countries
Norway
Outcome results
None listed